SR-17018 was created as a G-protein-biased MOP agonist, but reveals several pharmacological effects which can not be explained via the biased signaling speculation.Possibly most importantly for those with severe chronic pain, SR-17018 confirmed an power to present sustained discomfort reduction over time without having growth of tolerance, the situ